Evidence map›Paper›PMID 29263835›Full record

ArticleNPJ genomic medicine2017

Fourteen sequence variants that associate with multiple sclerosis discovered by meta-analysis informed by genetic correlations.

Sigurgeir Olafsson, Pernilla Stridh, Steffan Daniël Bos, Andres Ingason, Jack Euesden, Patrick Sulem, Gudmar Thorleifsson, Omar Gustafsson, Ari Johannesson, Arni J Geirsson and 43 more

Open access · goldAbstract read
In one paragraph

Article in NPJ genomic medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Improvement of Comorbid Psoriasis in Patients With MS Treated With Natalizumab.Neurology(R) neuroimmunology & neuroinflammation · 2021
    Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

53 authors at 12 institutions in 4 countries.

Sigurgeir OlafssondeCODE genetics/Amgen, Reykjavik, Iceland.ORCID 0000-0003-1711-2757
Pernilla StridhDepartment of Clinical Neuroscience, Karolinska Institutet, Center for Molecular Medicine, Stockholm, Sweden.
Steffan Daniël BosInstitute of Clinical Medicine, University of Oslo, Oslo, Norway.
Andres IngasondeCODE genetics/Amgen, Reykjavik, Iceland.
Jack EuesdendeCODE genetics/Amgen, Reykjavik, Iceland.
Patrick SulemdeCODE genetics/Amgen, Reykjavik, Iceland.ORCID 0000-0001-7123-6123
Gudmar ThorleifssondeCODE genetics/Amgen, Reykjavik, Iceland.
Omar GustafssondeCODE genetics/Amgen, Reykjavik, Iceland.
Ari JohannessonDepartment of Medicine, Landspitali, the National University Hospital of Iceland, Reykjavik, Iceland.
Arni J GeirssonDepartment of Medicine, Landspitali, the National University Hospital of Iceland, Reykjavik, Iceland.
Arni V ThorssonChildren's Medical Center, Landspitali, the National University Hospital of Iceland, Reykjavik, Iceland.
Bardur SigurgeirssonDepartment of Dermatology, Faculty of Medicine, School of Health Sciences, University of Iceland, Kopavogur, Iceland.
Bjorn Runar LudvikssonDepartment of Immunology, Landspitali, the National University Hospital of Iceland, Reykjavik, Iceland.
Elias OlafssonFaculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.
Helga KristjansdottirCenter for Rheumatology Research, Landspitali, the National University Hospital of Iceland, Reykjavik, Iceland.
Jon G JonassonFaculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.
Jon Hjaltalin OlafssonDepartment of Dermatology, Faculty of Medicine, School of Health Sciences, University of Iceland, Kopavogur, Iceland.
Kjartan B OrvarThe Medical Center, Glaesibae, Reykjavik, Iceland.
Rafn BenediktssonFaculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.
Ragnar BjarnasonChildren's Medical Center, Landspitali, the National University Hospital of Iceland, Reykjavik, Iceland.
Sjofn KristjansdottirThe Medical Center, Glaesibae, Reykjavik, Iceland.
Thorarinn GislasonFaculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.
Trausti ValdimarssonThe Medical Center, Glaesibae, Reykjavik, Iceland.
Evgenia MikaelsdottirdeCODE genetics/Amgen, Reykjavik, Iceland.
Snaevar SigurdssondeCODE genetics/Amgen, Reykjavik, Iceland.
Stefan JonssondeCODE genetics/Amgen, Reykjavik, Iceland.ORCID 0000-0001-5401-8589
Thorunn RafnardeCODE genetics/Amgen, Reykjavik, Iceland.
Dag AarslandDepartment of Old Age Psychiatry, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, UK.
Srdjan DjurovicDepartment of Medical Genetics, Oslo University Hospital, Oslo, Norway.
Tormod FladbyDepartment of Neurology, Akershus University Hospital, Lørenskog, Norway.
Gun Peggy KnudsenNorwegian Institute of Public Health, Oslo, Norway.
Elisabeth G CeliusDepartment of Neurology, Oslo University Hospital Ullevål, Oslo, Norway.
Kjell-Morten MyhrDepartment of Clinical Medicine, University of Bergen, Bergen, Norway.
Gerdur GrondalCenter for Rheumatology Research, Landspitali, the National University Hospital of Iceland, Reykjavik, Iceland.
Kristjan SteinssonCenter for Rheumatology Research, Landspitali, the National University Hospital of Iceland, Reykjavik, Iceland.
Helgi ValdimarssonDepartment of Immunology, Landspitali, the National University Hospital of Iceland, Reykjavik, Iceland.
Sigurdur BjornssonDepartment of Medicine, Landspitali, the National University Hospital of Iceland, Reykjavik, Iceland.
Unnur S BjornsdottirDepartment of Medicine, Landspitali, the National University Hospital of Iceland, Reykjavik, Iceland.
Einar S BjornssonDepartment of Medicine, Landspitali, the National University Hospital of Iceland, Reykjavik, Iceland.
Bjorn NilssonDepartment of Laboratory Medicine, Hematology and Transfusion Medicine, BMC, Lund, Sweden.
Ole A AndreassenDivision of Mental Health and Addiction, NORMENT, KG Jebsen Centre for Psychosis Research, Oslo University Hospital, Oslo, Norway.ORCID 0000-0002-4461-3568
Lars AlfredssonInstitute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Jan HillertDepartment of Clinical Neuroscience, Karolinska Institutet, Center for Molecular Medicine, Stockholm, Sweden.
Ingrid Skelton KockumDepartment of Clinical Neuroscience, Karolinska Institutet, Center for Molecular Medicine, Stockholm, Sweden.
Gisli MassondeCODE genetics/Amgen, Reykjavik, Iceland.
Unnur ThorsteinsdottirdeCODE genetics/Amgen, Reykjavik, Iceland.
Daniel F GudbjartssondeCODE genetics/Amgen, Reykjavik, Iceland.ORCID 0000-0002-5222-9857
Hreinn StefanssondeCODE genetics/Amgen, Reykjavik, Iceland.
Haukur HjaltasonFaculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.
Hanne F HarboInstitute of Clinical Medicine, University of Oslo, Oslo, Norway.
Tomas OlssonDepartment of Clinical Neuroscience, Karolinska Institutet, Center for Molecular Medicine, Stockholm, Sweden.
Ingileif JonsdottirdeCODE genetics/Amgen, Reykjavik, Iceland.ORCID 0000-0001-8339-150X
Kari StefanssondeCODE genetics/Amgen, Reykjavik, Iceland.
deCODE Genetics (Iceland) · ISUniversity of Iceland · ISNational University Hospital of Iceland · ISOslo University Hospital · NOKarolinska Institutet · SEAkershus University Hospital · NOHaukeland University Hospital · NOIcelandic Tourism Research Centre · ISKing's College London · GBLund University · SENorwegian Institute of Public Health · NOStockholm County Council · SE

Funding

Wellcome Trust
6 · The paper itself

Abstract

A meta-analysis of publicly available summary statistics on multiple sclerosis combined with three Nordic multiple sclerosis cohorts (21,079 cases, 371,198 controls) revealed seven sequence variants associating with multiple sclerosis, not reported previously. Using polygenic risk scores based on public summary statistics of variants outside the major histocompatibility complex region we quantified genetic overlap between common autoimmune diseases in Icelanders and identified disease clusters characterized by autoantibody presence/absence. As multiple sclerosis-polygenic risk scores captures the risk of primary biliary cirrhosis and vice versa (

Identifiers

PMID29263835
PMCPMC5677966
OpenAlexW2740350285

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.